The Association Between Prepandemic ICU Performance and Mortality Variation in COVID-19 A Multicenter Cohort Study of 35,619 Critically Ill Patients

被引:2
|
作者
Bastos, Leonardo S. L. [1 ]
Hamacher, Silvio [1 ]
Kurtz, Pedro [2 ]
Ranzani, Otavio T. [4 ,5 ]
Zampieri, Fernando G. [2 ,6 ]
Soares, Marcio [2 ]
Bozza, Fernando A. [2 ,3 ]
Salluh, Jorge I. F. [2 ,3 ]
机构
[1] Pontif Catholic Univ Rio De Janeiro, Dept Ind Engn, Rio De Janeiro, RS, Brazil
[2] Hosp Copa Star, Dor Inst Res & Educ, Paulo Niemeyer State Brain Inst, Rio De Janeiro, Brazil
[3] Univ Fed Rio de Janeiro, Oswaldo Cruz Fdn, Natl Inst Infect Dis Evandro Chagas, Postgrad Program Internal Med, Rio De Janeiro, Brazil
[4] Univ Sao Paulo, Hosp Clin HCFMUSP, Heart Inst, Fac Med,Pulm Div, Sao Paulo, Brazil
[5] Univ Pompeu Fabra, BarcelonaInstitute Global Hlth, ISGlobal, CIBER Epidemiol & Salud Publ, Barcelona, Spain
[6] Univ Alberta, Fac Med & Dent, Dept Crit Care Med, Edmonton, AB, Canada
基金
比尔及梅琳达.盖茨基金会;
关键词
COVID-19; ICU ef fi ciency; ICU organization; mortality; pandemic; INTENSIVE-CARE UNITS; RESOURCE USE; OUTCOMES; VOLUME;
D O I
10.1016/j.chest.2023.10.011
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
BACKGROUND: During the COVID-19 pandemic, ICUs remained under stress and observed elevated mortality rates and high variations of outcomes. A knowledge gap exists regarding whether an ICU performing best during nonpandemic times would still perform better when under high pressure compared with the least performing ICUs. RESEARCH QUESTION: Does prepandemic ICU performance explain the risk-adjusted mortality variability for critically ill patients with COVID-19? STUDY DESIGN AND METHODS: This study examined a cohort of adults with real-time polymerase chain reaction-confirmed COVID-19 admitted to 156 ICUs in 35 hospitals from February 16, 2020, through December 31, 2021, in Brazil. We evaluated crude and adjusted in-hospital mortality variability of patients with COVID-19 in the ICU during the pandemic. Association of baseline (prepandemic) ICU performance and in-hospital mortality was examined using a variable life-adjusted display (VLAD) during the pandemic and a multivariable mixed regression model adjusted by clinical characteristics, interaction of performance with the year of admission, and mechanical ventilation at admission. RESULTS: Thirty-five thousand six hundred nineteen patients with confirmed COVID-19 were evaluated. The median age was 52 years, median Simplified Acute Physiology Score 3 was 42, and 18% underwent invasive mechanical ventilation. In-hospital mortality was 13% and 54% for those receiving invasive mechanical ventilation. Adjusted in-hospital mortality ranged from 3.6% to 63.2%. VLAD in the most efficient ICUs was higher than the overall median in 18% of weeks, whereas VLAD was 62% and 84% in the underachieving and least efficient groups, respectively. The least efficient baseline ICU performance group was associated independently with increased mortality (OR, 2.30; 95% CI, 1.45-3.62) after adjusting for patient characteristics, disease severity, and pandemic surge. INTERPRETATION: ICUs caring for patients with COVID-19 presented substantial variation in reduced mortality and less variability. Our findings suggest that achieving ICU efficiency by targeting improvement in organizational aspects of ICUs may impact outcomes, and therefore should be a part of the preparedness for future pandemics.
引用
收藏
页码:870 / 880
页数:11
相关论文
共 50 条
  • [1] Predictors of COVID-19 Mortality in Critically Ill ICU Patients: A Multicenter Retrospective Observational Study
    Umeh, Chukwuemeka
    Tuscher, Laura
    Ranchithan, Sobiga
    Watanabe, Kimberly
    Gupta, Rahul
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (01)
  • [2] Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study
    Al Harbi, Shmeylan
    Kensara, Raed
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Altebainawi, Ali F.
    Al Harthi, Abdullah
    Vishwakarma, Ramesh
    Alenazi, Alaa M.
    Almutairi, Abdulmajed
    Alshaya, Omar
    Alraddadi, Sultan
    Al Sulaiman, Tareq
    Aldakkan, Latifah
    Mahboob, Reem
    Alaamer, Kholoud
    Alissa, Abdulrahman
    Hafiz, Awatif
    Aldhayyan, Nada
    Althewaibi, Sara
    Alenezi, Farhan
    Alkhotani, Nadeen Y.
    Alghamdi, Sara A.
    Alenazi, Abeer A.
    Al Sulaiman, Khalid
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28
  • [3] The association between reduced calf and mid-arm circumferences and ICU mortality in critically ill COVID-19 patients
    Santer, Danieli
    Schneider, Nicole
    de Carvalho, Yasmim Sena Silva
    Bortolini, Renata Vieira de Souza
    Silva, Flavia Moraes
    Franken, Debora Luiza
    Fink, Jaqueline da Silva
    CLINICAL NUTRITION ESPEN, 2023, 54 : 45 - 51
  • [4] Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study
    Al Sulaiman, Khalid
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Alnajjar, Lina I.
    Altebainawi, Ali F.
    Alfaifi, Mashael
    Vishwakarma, Ramesh
    Alenazi, Abeer A.
    Alalawi, Mai
    Alissa, Abdulrahman
    Alsowaida, Yazed S.
    Alsohimi, Samiah
    Almagthali, Alaa
    Alay, Saeed M.
    Altaher, Noora
    Alamri, Mohammed G.
    Alangari, Dalal
    Alzahrani, Amer
    Abdul Razack, Habeeb Ibrahim
    Alhamoud, Jwael
    Alshaya, Abdulrahman
    Gramish, Jawaher
    Al Aamer, Kholoud
    Alsaeedi, Alawi S.
    Alghamdi, Ghassan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [5] Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
    Matthieu Raymond
    Aurélie Le Thuaut
    Pierre Asfar
    Cédric Darreau
    Florian Reizine
    Gwenhaël Colin
    Charly Dano
    Julien Lorber
    Baptiste Hourmant
    Agathe Delbove
    Aurélien Frérou
    Jean Morin
    Pierre Yves Egreteau
    Philippe Seguin
    Jean Reignier
    Jean-Baptiste Lascarrou
    Emmanuel Canet
    Annals of Intensive Care, 12
  • [6] Doxycycline's Potential Role in Reducing Thrombosis and Mortality in Critically Ill Patients With COVID-19: A Multicenter Cohort Study
    Al Sulaiman, Khalid
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Alnajjar, Lina I.
    Altebainawi, Ali F.
    AlFaifi, Mashael
    Vishwakarma, Ramesh
    Alenazi, Abeer A.
    Alalawi, Mai
    Alissa, Abdulrahman
    Alsowaida, Yazed S.
    Alsohimi, Samiah
    Almagthali, Alaa
    Alay, Saeed M.
    Altaher, Noora
    Alamri, Mohammed G.
    Alangari, Dalal
    Alzahrani, Amer
    Razack, Habeeb Ibrahim Abdul
    Alhamoud, Jwael
    Alshaya, Abdulrahman
    Gramish, Jawaher
    Al Aamer, Kholoud
    Alsaeedi, Alawi S.
    Alghamdi, Ghassan
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2023, 29
  • [7] Association of early dexamethasone therapy with mortality in critically Ill COVID-19 patients: a French multicenter study
    Raymond, Matthieu
    Le Thuaut, Aurelie
    Asfar, Pierre
    Darreau, Cedric
    Reizine, Florian
    Colin, Gwenhael
    Dano, Charly
    Lorber, Julien
    Hourmant, Baptiste
    Delbove, Agathe
    Frerou, Aurelien
    Morin, Jean
    Egreteau, Pierre Yves
    Seguin, Philippe
    Reignier, Jean
    Lascarrou, Jean-Baptiste
    Canet, Emmanuel
    ANNALS OF INTENSIVE CARE, 2022, 12 (01)
  • [8] The Association between Nutritional Status and In-Hospital Mortality of COVID-19 in Critically-Ill Patients in the ICU
    Czapla, Michal
    Juarez-Vela, Raul
    Gea-Caballero, Vicente
    Zielinski, Stanislaw
    Zielinska, Marzena
    NUTRIENTS, 2021, 13 (10)
  • [9] Early corticosteroids are associated with lower mortality in critically ill patients with COVID-19: a cohort study
    Pablo Monedero
    Alfredo Gea
    Pedro Castro
    Angel M. Candela-Toha
    María L. Hernández-Sanz
    Egoitz Arruti
    Jesús Villar
    Carlos Ferrando
    Critical Care, 25
  • [10] Statins and Risk of Thrombosis in Critically ill Patients with COVID-19: A Multicenter Cohort Study
    Al Harbi, Shmeylan
    Kensara, Raed
    Aljuhani, Ohoud
    Korayem, Ghazwa B.
    Altebainawi, Ali F.
    Al Harthi, Abdullah
    Vishwakarma, Ramesh
    Alenazi, Alaa M.
    Almutairi, Abdulmajed
    Alshaya, Omar
    Alraddadi, Sultan
    Al Sulaiman, Tareq
    Aldakkan, Latifah
    Mahboob, Reem
    Alaamer, Kholoud
    Alissa, Abdulrahman
    Hafiz, Awatif
    Aldhayyan, Nada
    Althewaibi, Sara
    Alenezi, Farhan
    Alkhotani, Nadeen Y.
    Alghamdi, Sara A.
    Alenazi, Abeer A.
    Al Sulaiman, Khalid
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2022, 28